CLINICAL_TRIALS
trial_result
· 2022-09-16
Clinical Trial Update: Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia [Phase 2]
Summary
Phase 2 trial updates the efficacy and safety of NYX-2925 in fibromyalgia, with results posted after completion.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aptinyx | Conditions: Fibromyalgia | Phase 2 | Status: COMPLETED | Results posted: 2022-09-16